ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $158,000 | -48.4% | 11,412 | +4.8% | 0.00% | -40.0% |
| Q4 2021 | $306,000 | -18.2% | 10,894 | -1.1% | 0.01% | -28.6% |
| Q3 2021 | $374,000 | -18.2% | 11,016 | -1.6% | 0.01% | -12.5% |
| Q2 2021 | $457,000 | +38.9% | 11,193 | +37.0% | 0.01% | +14.3% |
| Q1 2021 | $329,000 | -28.5% | 8,168 | +5.0% | 0.01% | -30.0% |
| Q4 2020 | $460,000 | +18.6% | 7,778 | -2.4% | 0.01% | 0.0% |
| Q3 2020 | $388,000 | +7.2% | 7,971 | +6.6% | 0.01% | +11.1% |
| Q2 2020 | $362,000 | – | 7,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |